Lepore JJ, Olson E, Demopoulos L, Haws T, Fang Z, Barbour AM, Fossler M, Davila-Roman VG, Russell SD, Gropler RJ (2016) Effects of the novel long-acting GLP-1 agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction
However, semaglutide stands out as an available oral option, offering a convenient and weekly alternative for individuals who may have difficulty with injections
When it comes to picking which part of the body to inject into, it is best to select a fleshy area where the skin is thick and that is well away from veins and muscles
Methyl B12 is the most promising treatment for patients with severe neurological symptoms, bypassing several steps in the absorption cycle and helping to relieve or completely reverse symptoms
Why they matter: Cardiovascular outcome trials (LEADER, SUSTAIN-6, REWIND, SELECT) have shown reductions in major adverse cardiovascular events